NDC 51808-217

Bicisate

Bicisate

Bicisate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Bicisate.

Product ID51808-217_b780bd14-67f7-4dd6-8d36-f53a6d38152c
NDC51808-217
Product TypeHuman Prescription Drug
Proprietary NameBicisate
Generic NameBicisate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-05-23
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameBICISATE
Active Ingredient Strength1 mg/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-217-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 KIT (51808-217-01)
Marketing Start Date2012-05-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-217-01 [51808021701]

Bicisate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
BICISATE1.35 mg/1

OpenFDA Data

SPL SET ID:e094cb1d-80fe-4277-b8f4-9817918f8c76
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.